H. D. Smith acquires California drug wholesaler, Valley Wholesale Drug
Valley had $130 million in 2011 revenue
H. D. Smith (Springfield, IL), the No. 4 drug wholesaler in the US (based on annual revenue) and the largest privately held one, has completed the acquisition of Valley Wholesale Drug, a family-run business in Stockton, CA, serving 600 independent pharmacies in that state and a few in Nevada. Valley has a single distribution center in Stockton; H. D. Smith has one in Carson, CA, as well as six other states. Stephen Shoneff, former CEO of Valley, will manage the Valley business. Purchase price was not disclosed.
"The close of the acquisition of Valley Wholesale Drug marks a significant step in our strategy to continue growing our national footprint to serve more independent pharmacists across the country — especially in the critical market of California, and moving forward, into the Pacific Northwest," said Dale Smith, chairman, H. D. Smith. "We will continue to focus on exceptional service to our core customers – the Retail Independent Pharmacy – and we will be well-served to execute on this objective under the leadership of Stephen Shoneff, who has managed the Valley Wholesale Drug business successfully during the last 26 years."
US drug wholesaling has been consolidating steadily over the past two decades, with the Big Three—AmerisourceBergen, Cardinal Health and McKesson—roughly splitting some 90% of the industry. In the 2010-2011 HDMA Factbook, H. D. Smith was listed as having 2009 revenue of $3.34 billion.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
